All
LDN for ME/CFS: Fatigue, Post-Exertional Malaise, Long COVID, and GLP-1 Risks

LDN for ME/CFS: Fatigue, Post-Exertional Malaise, Long COVID, and GLP-1 Risks

LDN for ME/CFS has retrospective, case-report, and laboratory signals, but no published result has established reliable control of fatigue or post-exertional malaise. Compare the evidence,...

Read article
LDN for Depression and Anxiety: What the Evidence Shows

LDN for Depression and Anxiety: What the Evidence Shows

Can LDN help depression or anxiety? A 12-person pilot reported encouraging signals on some secondary depression scales, but its primary comparison was not statistically significant....

Read article
LDN for Migraine and Chronic Headache: What the Evidence Actually Shows

LDN for Migraine and Chronic Headache: What the Evidence Actually Shows

LDN is increasingly discussed as a possible migraine treatment, but the direct evidence is much smaller than online enthusiasm suggests. The published record includes two...

Read article
Does LDN Help With Weight Loss?  How It Differs From Contrave and GLP-1s

Does LDN Help With Weight Loss? How It Differs From Contrave and GLP-1s

LDN, Contrave, and GLP-1 medicines are increasingly mentioned in the same weight-loss conversation, but they are not interchangeable. Naltrexone alone failed to produce significant overall...

Read article
LDN for POTS: Evidence, Symptoms, and GLP-1 Safety

LDN for POTS: Evidence, Symptoms, and GLP-1 Safety

LDN is gaining attention in POTS communities, but does it actually lower standing heart rate or improve fatigue? The direct evidence is limited to very...

Read article
LDN for IBS: Evidence, Gut Motility, and GLP-1s

LDN for IBS: Evidence, Gut Motility, and GLP-1s

Could LDN help IBS pain, constipation, or diarrhea? A 42-person pilot looked encouraging, but a 609-woman Phase 3 trial missed its primary endpoint. Explore the...

Read article